Vantage Consulting Group Inc Ionis Pharmaceuticals Inc Transaction History
Vantage Consulting Group Inc
- $9.74 Million
- Q3 2025
Shares
2 transactions
Others Institutions Holding IONS
# of Institutions
464Shares Held
177MCall Options Held
1.98MPut Options Held
836K-
Dld Asset Management, LP New York, NY25MShares$1.75 Billion7.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$1.15 Billion0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16MShares$1.12 Billion0.4% of portfolio
-
Capital World Investors Los Angeles, CA12.7MShares$889 Million0.12% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$721 Million0.01% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $9.91B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...